Stock listing

MMQ0 Stock Price, News, Filings & Events — Definium Therapeutics, Inc.

Selected listing: MMQ0 · SWB · EUR · DE

This page tracks Definium Therapeutics, Inc.'s MMQ0:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MMQ0:SWB. MMQ0:SWB is the stock-level entry point for investors researching Definium Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Definium Therapeutics, Inc. (Ticker: DFTX) is a public company based in the United States, with a market capitalization of approximately $5.73 billion. The company is focused on developing innovative therapeutic solutions. As a publicly traded entity, Definium Therapeutics is listed on the American market, providing investors with opportunities to engage with its growth and advancements in the healthcare sector.

MMQ0:SWBEURDEUpdated August 22, 2026
Definium Therapeutics, Inc. logo
Ticker
MMQ0:SWB
Asset type
Stock
Market cap
$6.03B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
SWB
Currency
EUR

Definium Therapeutics, Inc. MMQ0:SWB stock context

This page tracks Definium Therapeutics, Inc.'s MMQ0:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MMQ0:SWB. MMQ0:SWB is the stock-level entry point for investors researching Definium Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Definium Therapeutics, Inc. (Ticker: DFTX) is a public company based in the United States, with a market capitalization of approximately $5.73 billion. The company is focused on developing innovative therapeutic solutions. As a publicly traded entity, Definium Therapeutics is listed on the American market, providing investors with opportunities to engage with its growth and advancements in the healthcare sector.

Latest news from Definium Therapeutics, Inc.

All Definium Therapeutics, Inc. news →

Definium Therapeutics, Inc. earnings calls

Research Definium Therapeutics, Inc.

Alternate listings